Table 4:
GEE model estimates for Severe AKI ~ treatment arm
| AKI groups | OR (95% CI) | |
|---|---|---|
| Early AKI | ||
| NO vs 1/2/3 | 0.93 (0.62, 1.41) | |
| NO or 1 vs 2/3 | 0.79 (0.32, 1.95) | |
| Middle AKI | ||
| NO vs 1/2/3 | 0.99 (0.69, 1.44) | |
| NO or 1 vs 2/3 | 0.67 (0.38, 1.20) | |
| Late AKI | ||
| NO vs 1/2/3 | 1.04 (0.76, 1.42) | |
| NO or 1 vs 2/3 | 0.86 (0.58, 1.25) | |
| Anytime AKI | ||
| NO vs 1/2/3 | 1.11 (0.83, 1.48) | |
| NO or 1 vs 2/3 | 0.76 (0.54, 1.07) |
GEE models accouting for GA, sex, site and sibship clustering.
Estimates shown only for treatment arm - Epo vs Placebo